Fulltext

Microalbuminuria prevalence study in hypertensive type 2 diabetic patients in Malaysia

Kong NC 1 , Chia YC 2 , Khalid BA 3 , Juwita S 4 , Samiah Yasmin AK 5 , Yap LY 2 Show all authors , Norlaila M 3 , Menon J , Tan C 6 , Fung YK 7 , MAPS Investigators 7

Affiliations 

  • 1 Department of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpu
  • 2 Department of Family Medicine, Universiti Malaya, Kuala Lumpur
  • 3 Department of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur
  • 4 Department of Family Medicine, Universiti Sains Malaysia, Kubang Kerian
  • 5 Department of Family Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur
  • 6 General Medicine Department, Queen Elizabeth Hospital, Kota Kinabalu
  • 7 General Medicine Department, Kuching General Hospital, Sarawak, Malaysia
Med J Malaysia, 2006 Oct;61(4):457-65.
PMID: 17243524 MyJurnal

Abstract

Microalbuminuria is the earliest indicator of diabetic kidney disease and generalised vascular endothelial dysfunction. The Microalbuminuria Prevalence (MAP) Study was carried out to assess the prevalence of macroalbuminuria, microalbuminuria and normoalbuminuria in Asian hypertensive patients with type 2 diabetes on usual care. This paper presents a subanalysis of data from patients in Malaysia. In 733 analysed patients, the prevalence of macroalbuminuria and microalbuminuria was 15.7% and 39.7%, respectively. The high prevalence of diabetic nephropathy in these high-risk patients is a cause for concern, and the Malaysian Health Care system should be prepared for a pandemic of end-stage renal disease due to diabetic nephropathy.

Study site: six medical centres in Kuala Lumpur, Kota Bharu,
Kuching and Kota Kinabalu

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications